Andreas Petzer

5.9k total citations
111 papers, 3.3k citations indexed

About

Andreas Petzer is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Andreas Petzer has authored 111 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 42 papers in Oncology and 31 papers in Genetics. Recurrent topics in Andreas Petzer's work include Hematopoietic Stem Cell Transplantation (23 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Andreas Petzer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Andreas Petzer collaborates with scholars based in Austria, Germany and Canada. Andreas Petzer's co-authors include Connie J. Eaves, Eibhlin Conneally, Peter W. Zandstra, James M. Piret, Eberhard Gunsilius, John R. Cashman, Günther Gastl, Donna E. Hogge, Allen Eaves and Kurt Grünewald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Andreas Petzer

105 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Petzer Austria 26 1.8k 977 946 879 830 111 3.3k
Reinier Raymakers Netherlands 33 1.8k 1.0× 1.5k 1.6× 891 0.9× 748 0.9× 745 0.9× 109 3.6k
Carol D. Jones United States 23 1.3k 0.7× 1.3k 1.4× 921 1.0× 801 0.9× 1.1k 1.4× 54 3.7k
Javier Briones Spain 35 1.0k 0.6× 831 0.9× 1.9k 2.0× 1.7k 1.9× 957 1.2× 161 4.5k
Shigeo Horiike Japan 31 2.1k 1.2× 1.6k 1.7× 935 1.0× 550 0.6× 933 1.1× 165 4.1k
Eric Wattel France 34 2.0k 1.1× 1.4k 1.4× 759 0.8× 1.4k 1.6× 1.2k 1.4× 132 4.5k
C. Cameron Yin United States 37 1.7k 0.9× 950 1.0× 1.4k 1.5× 841 1.0× 1.7k 2.0× 226 4.6k
Marco Gobbi Italy 33 1.9k 1.1× 1.0k 1.0× 1.3k 1.4× 969 1.1× 896 1.1× 171 3.9k
Stephen T. Oh United States 27 1.6k 0.9× 1.4k 1.5× 909 1.0× 1.0k 1.2× 1.6k 2.0× 151 3.7k
Go Yamamoto Japan 26 845 0.5× 1.2k 1.2× 645 0.7× 634 0.7× 319 0.4× 121 2.9k
Gesine Bug Germany 35 2.3k 1.3× 1.6k 1.6× 1.3k 1.4× 1.2k 1.4× 648 0.8× 141 4.2k

Countries citing papers authored by Andreas Petzer

Since Specialization
Citations

This map shows the geographic impact of Andreas Petzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Petzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Petzer more than expected).

Fields of papers citing papers by Andreas Petzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Petzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Petzer. The network helps show where Andreas Petzer may publish in the future.

Co-authorship network of co-authors of Andreas Petzer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Petzer. A scholar is included among the top collaborators of Andreas Petzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Petzer. Andreas Petzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buxhofer‐Ausch, Veronika, Sigrid Machherndl‐Spandl, Michaela Binder, et al.. (2023). Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis. Vaccines. 11(10). 1534–1534. 2 indexed citations
2.
Machherndl‐Spandl, Sigrid, Veronika Buxhofer‐Ausch, Michaela Binder, et al.. (2023). Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience. Cancers. 15(24). 5738–5738. 2 indexed citations
3.
Doleschal, Bernhard, et al.. (2023). Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis. Oncology. 102(2). 107–113. 3 indexed citations
4.
Bartsch, Rupert, Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al.. (2022). Updated Austrian treatment algorithm in HER2+ metastatic breast cancer. Wiener klinische Wochenschrift. 134(1-2). 63–72. 2 indexed citations
5.
Gampenrieder, Simon Peter, Gabriel Rinnerthaler, Christoph Tinchon, et al.. (2021). Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry. Breast Cancer Research. 23(1). 112–112. 94 indexed citations
6.
Geinitz, Hans, Carsten Nieder, J. Feichtinger, et al.. (2020). Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study. Radiation Oncology. 15(1). 111–111. 3 indexed citations
7.
8.
Ludwig, Heinz, Stefan Knop, Alexander Egle, et al.. (2019). Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma. British Journal of Cancer. 121(9). 751–757. 17 indexed citations
9.
Haslbauer, Ferdinand, Andreas Petzer, Antoaneta Tomova, et al.. (2019). Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis. Supportive Care in Cancer. 28(4). 1855–1865. 5 indexed citations
10.
11.
Webersinke, Gerald, et al.. (2017). MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma. Clinical & Experimental Metastasis. 34(6-7). 431–440. 10 indexed citations
12.
Doleschal, Bernhard, Andreas Petzer, & Karl J. Aichberger. (2017). Adrenal crisis in metastatic breast cancer. BMJ Case Reports. 2017. bcr–2017. 1 indexed citations
13.
14.
Zech, Nicolas H., et al.. (2003). Expansion of Mobilized Peripheral Blood Progenitor Cells under Defined Culture Conditions Using CD34 + CD71 - CD45 - Cells as a Starting Population. Journal of Hematotherapy & Stem Cell Research. 12(4). 367–373. 3 indexed citations
15.
Petzer, Andreas, Margot Haun, Kurt Grünewald, et al.. (2002). High-Dose Hydroxyurea Plus G-CSF Mobilize BCR-ABL-Negative Progenitor Cells (CFC, LTC-IC) into the Blood of Newly Diagnosed CML Patients at Any Time of Hematopoietic Regeneration. Journal of Hematotherapy & Stem Cell Research. 11(2). 293–300. 6 indexed citations
16.
Gunsilius, Eberhard, Jörg Tschmelitsch, H. G. Schwelberger, et al.. (2002). In vivo Release of Vascular Endothelial Growth Factor from Colorectal Carcinomas. Oncology. 62(4). 313–317. 14 indexed citations
17.
Clausen, Johannes, et al.. (2001). Optimal Timing for the Collection and In Vitro Expansion of Cytotoxic CD56 + Lymphocytes from Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 10(4). 513–521. 10 indexed citations
18.
Gunsilius, Eberhard, Günther Gastl, & Andreas Petzer. (2001). Hematopoietic stem cells. Biomedicine & Pharmacotherapy. 55(4). 186–194. 58 indexed citations
19.
Gunsilius, Eberhard, Andreas Petzer, Christian M. Kähler, et al.. (2000). Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. The Lancet. 355(9216). 1688–1691. 245 indexed citations
20.
Holyoake, Tessa L., G Konwalinka, Marcela Haun, et al.. (1993). Mixed colony formation in vitro by the heterogeneous compartment of multipotential progenitors in human bone marrow.. PubMed. 7(2). 207–13. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reinier Raymakers Breakdown of academic impact, for papers by Carol D. Jones Breakdown of academic impact, for papers by Javier Briones Breakdown of academic impact, for papers by Shigeo Horiike Breakdown of academic impact, for papers by Eric Wattel Breakdown of academic impact, for papers by C. Cameron Yin Breakdown of academic impact, for papers by Marco Gobbi Breakdown of academic impact, for papers by Stephen T. Oh Breakdown of academic impact, for papers by Go Yamamoto Breakdown of academic impact, for papers by Gesine Bug
Rankless by CCL
2026